Acucela Provides Update on Emixustat Phase 3 Clinical Trial in Patients with Stargardt Disease | Business Wire
Retina News - Retina Today
Emixustat - Wikipedia
Emixustat Hydrochloride for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Clinical Trial - ScienceDirect
Randomised study evaluating the pharmacodynamics of emixustat hydrochloride in subjects with macular atrophy secondary to Stargardt disease | British Journal of Ophthalmology
Phase 2a trial results for emixustat hydrochloride published
Retinal Physician - Pharmacodynamics Of Visual Cycle Modulation In the Treatment of GA
Biomolecules | Free Full-Text | Therapy Approaches for Stargardt Disease | HTML
Emixustat preclinical data published
Retinal Physician - Pharmacodynamics Of Visual Cycle Modulation In the Treatment of GA
Emixustat | C16H25NO2 - PubChem
Modern Medicines: Drugs in Clinical Pipeline: Emixustat | Modulator of Retinal Pigment Epithelium 65 (RPE65) | Treatment of Age-related Macular Degeneration (AMD)
Acucela begins Phase ll trial of emixustat to treat PDR - Clinical Trials Arena
Acucela Announces End of Clinical Trial Treatment Period for Emixustat Hydrochloride | OphthalmologyWeb: The Ultimate Online Resource for Ophthalmologists
Emixustat (ACU-4429) | Visual Cycle Isomerase Inhibitor | MedChemExpress
Emixustat - Wikipedia
Emerging Treatment: Diabetic Eye Diseases - OE Patients
Reduced Lipofuscin Autofluorescence and A2E Accumulation. The effect of... | Download Scientific Diagram
Emerging therapies and their delivery for treating age‐related macular degeneration - Thomas - 2022 - British Journal of Pharmacology - Wiley Online Library
PDF) Effects of emixustat hydrochloride in patients with proliferative diabetic retinopathy: a randomized, placebo-controlled phase 2 study
/5C821B7857B0B91A802586B1003ECBA2/$file/RVB93497_structure.png "Emixustat hydrochloride | 1141934-97-5 | Biosynth Carbosynth")
Emixustat hydrochloride | 1141934-97-5 | Biosynth Carbosynth
Jobs with Acucela Inc.
Emixustat for Proliferative Diabetic Retinopathy | Kubota Pharmaceutical Holdings Co., Ltd.
